Michelle Corral
Investor Relations Contact bei TENAYA THERAPEUTICS, INC.
Profil
Michelle Corral is currently the President & Director at Mason General Hospital and the VP-Investor Relations & Communications at Tenaya Therapeutics, Inc. She previously worked as the Senior Director-Corporate Communications at OncoMed Pharmaceuticals, Inc. and as the Senior Director-Corporate Communications & IR at MyoKardia, Inc. from 2017 to 2021.
She also worked as the VP-Communications & Investor Relations at Alector, Inc. from 2021 to 2022.
Aktive Positionen von Michelle Corral
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Investor Relations Contact | - |
Mason General Hospital
 Mason General Hospital Hospital/Nursing ManagementHealth Services Mason General Hospital owns and operates hospital. It offers birth center, diagnostic imaging, hospitalist program, respiratory care, telemedicine, breast cancer navigation, emergency and rehabilitation services, surgery, wound care, and ostomy services. The company was founded in 1968 and is headquartered in Shelton, WA. | President | - |
Ehemalige bekannte Positionen von Michelle Corral
| Unternehmen | Position | Ende |
|---|---|---|
| ALECTOR, INC. | Investor Relations Contact | 01.04.2022 |
| MYOKARDIA, INC. | Investor Relations Contact | 01.02.2021 |
| ONCOMED PHARMACEUTICALS INC | Investor Relations Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALECTOR, INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Mason General Hospital
Mason General Hospital Hospital/Nursing ManagementHealth Services Mason General Hospital owns and operates hospital. It offers birth center, diagnostic imaging, hospitalist program, respiratory care, telemedicine, breast cancer navigation, emergency and rehabilitation services, surgery, wound care, and ostomy services. The company was founded in 1968 and is headquartered in Shelton, WA. | Health Services |
